Compare FCBM & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FCBM | NAUT |
|---|---|---|
| Founded | 2012 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Laboratory Analytical Instruments |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 404.8M | 347.7M |
| IPO Year | 2026 | 2020 |
| Metric | FCBM | NAUT |
|---|---|---|
| Price | $13.06 | $2.18 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $15.00 | $4.00 |
| AVG Volume (30 Days) | 131.3K | ★ 6.9M |
| Earning Date | 10-27-2026 | 10-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 16.07 |
| EPS | ★ 0.71 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $22.18 | $708.84 |
| P/E Ratio | $18.54 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.17 | $0.84 |
| 52 Week High | $14.00 | $4.31 |
| Indicator | FCBM | NAUT |
|---|---|---|
| Relative Strength Index (RSI) | 46.90 | 47.34 |
| Support Level | $12.40 | $1.61 |
| Resistance Level | $13.40 | $2.46 |
| Average True Range (ATR) | 0.33 | 0.26 |
| MACD | -0.04 | -0.06 |
| Stochastic Oscillator | 11.36 | 20.27 |
First Carolina Financial Services Inc is a bank holding company. The company's activities consist of managing and owning the Bank and its direct and indirect subsidiaries. The Bank provides commercial banking, payment, consumer banking, and wealth management services to small and medium-sized businesses, individuals, professionals, as well as institutions of higher education. It has four primary lines of business: Commercial Banking, Payments, Consumer Banking and Wealth Management. The reportable segments are Community Banking and BM Tech. The majority of revenue is derived from the Community Banking segment, which comprises activities of a traditional banking institution, gathering deposits and originating loans for portfolio in its respective primary market areas.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.